CN101254266A - 一种治疗心脑血管疾病的药物 - Google Patents
一种治疗心脑血管疾病的药物 Download PDFInfo
- Publication number
- CN101254266A CN101254266A CNA2007100344911A CN200710034491A CN101254266A CN 101254266 A CN101254266 A CN 101254266A CN A2007100344911 A CNA2007100344911 A CN A2007100344911A CN 200710034491 A CN200710034491 A CN 200710034491A CN 101254266 A CN101254266 A CN 101254266A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- fructus
- bulbus allii
- radix salviae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 90
- 230000000747 cardiac effect Effects 0.000 title 1
- 230000002490 cerebral effect Effects 0.000 title 1
- 208000019553 vascular disease Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 claims abstract description 31
- 208000026106 cerebrovascular disease Diseases 0.000 claims abstract description 13
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 13
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 12
- 238000011282 treatment Methods 0.000 claims abstract description 11
- 235000003935 Hippophae Nutrition 0.000 claims description 29
- 241000229143 Hippophae Species 0.000 claims description 29
- 239000000843 powder Substances 0.000 claims description 17
- 241000237903 Hirudo Species 0.000 claims description 15
- 241000219780 Pueraria Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 22
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 14
- 208000026435 phlegm Diseases 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000003213 activating effect Effects 0.000 abstract description 9
- 238000002156 mixing Methods 0.000 abstract description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 238000012360 testing method Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- 210000004351 coronary vessel Anatomy 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 208000031225 myocardial ischemia Diseases 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000008899 fufang danshen Substances 0.000 description 6
- 210000000115 thoracic cavity Anatomy 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000010125 myocardial infarction Diseases 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010061216 Infarction Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000007574 infarction Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 208000007718 Stable Angina Diseases 0.000 description 2
- 208000007814 Unstable Angina Diseases 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- KCVIRDLVBXYYKD-UHFFFAOYSA-O 1-nitrotetrazol-2-ium Chemical compound [O-][N+](=O)[NH+]1C=NN=N1 KCVIRDLVBXYYKD-UHFFFAOYSA-O 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 241000218628 Ginkgo Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 201000001068 Prinzmetal angina Diseases 0.000 description 1
- 241000630329 Scomberesox saurus saurus Species 0.000 description 1
- 208000009325 Variant Angina Pectoris Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 229960004588 cilostazol Drugs 0.000 description 1
- RRGUKTPIGVIEKM-UHFFFAOYSA-N cilostazol Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCC1=NN=NN1C1CCCCC1 RRGUKTPIGVIEKM-UHFFFAOYSA-N 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000009465 diaoxinxuekang Substances 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 239000010212 ginaton Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000010068 shuxuening Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100344911A CN101254266B (zh) | 2007-03-02 | 2007-03-02 | 一种治疗心脑血管疾病的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100344911A CN101254266B (zh) | 2007-03-02 | 2007-03-02 | 一种治疗心脑血管疾病的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101254266A true CN101254266A (zh) | 2008-09-03 |
CN101254266B CN101254266B (zh) | 2011-02-16 |
Family
ID=39889589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100344911A Active CN101254266B (zh) | 2007-03-02 | 2007-03-02 | 一种治疗心脑血管疾病的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101254266B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142819A (zh) * | 2013-03-22 | 2013-06-12 | 江苏省中医药研究院 | 一种防治心肌纤维化或心肌肥厚的中药组合物 |
CN104352736A (zh) * | 2014-11-25 | 2015-02-18 | 山西金科海生物制品有限公司 | 一种预防与治疗血管性痴呆的药食两用组合物及制备方法 |
CN110559337A (zh) * | 2019-10-17 | 2019-12-13 | 苏亚楠 | 一种调节三高的中药组合物 |
-
2007
- 2007-03-02 CN CN2007100344911A patent/CN101254266B/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142819A (zh) * | 2013-03-22 | 2013-06-12 | 江苏省中医药研究院 | 一种防治心肌纤维化或心肌肥厚的中药组合物 |
CN103142819B (zh) * | 2013-03-22 | 2015-07-15 | 江苏省中医药研究院 | 一种防治心肌纤维化或心肌肥厚的中药组合物 |
CN104352736A (zh) * | 2014-11-25 | 2015-02-18 | 山西金科海生物制品有限公司 | 一种预防与治疗血管性痴呆的药食两用组合物及制备方法 |
CN110559337A (zh) * | 2019-10-17 | 2019-12-13 | 苏亚楠 | 一种调节三高的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101254266B (zh) | 2011-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101104048B (zh) | 生脉冠心复方药物 | |
CN102114231B (zh) | 一种治疗心律失常的药物 | |
CN103479969B (zh) | 一种治疗癫狂病的药物及其制备方法 | |
CN102940785A (zh) | 一种治疗眩晕症的中药组合物 | |
CN101254266B (zh) | 一种治疗心脑血管疾病的药物 | |
CN101095768A (zh) | 一种治疗中老年原发性高血压的中药胶囊 | |
CN103230457B (zh) | 一种治疗病毒性心肌炎的中药组合物及其制备方法与用途 | |
CN109528968A (zh) | 一种治疗2型糖尿病的中药组合物及其制备方法和应用 | |
CN104324134B (zh) | 一种改善微循环的中药组合物及其制备方法 | |
CN105831751A (zh) | 补气健脑的中药保健组合物、制备方法及其使用方法 | |
CN101757423B (zh) | 一种治疗心肌炎的中药组合物及其制备方法 | |
CN101417075B (zh) | 一种治疗呼吸系统疾病的中药 | |
CN106620253B (zh) | 一种治疗缓慢性心律失常的中药组合物 | |
CN105106734A (zh) | 一种治疗妊娠恶阻的中药制剂 | |
CN105056077A (zh) | 一种治疗功能性消化不良的中药组合物 | |
CN110882347A (zh) | 一种治疗心血管疾病的中药组合物 | |
CN110339323A (zh) | 一种治疗心动过缓的中药组合物及其制备方法和应用 | |
CN103599485B (zh) | 一种用于治疗早搏的中药组合物 | |
CN102631618A (zh) | 一种治疗糖尿病的中药 | |
CN112618656B (zh) | 治疗妇女更年期综合征的中药组合物及其用途 | |
CN102784376B (zh) | 一种治疗纳呆型急性肾小球肾炎的中药制备方法 | |
CN103182035B (zh) | 用于治疗老年慢性心律失常的中药组合物及其制备方法 | |
CN102772665B (zh) | 一种治疗阴虚内热型病毒性心肌炎的中药制剂及其制备方法 | |
CN104940554A (zh) | 一种治疗心脏病的中药组合物 | |
CN102836320B (zh) | 治疗快速型心律失常的中药丸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: PUDAO MEDICINE TECHNOLOGY CO., LTD., HUNAN PROV. Free format text: FORMER OWNER: DUAN LIXIN Effective date: 20141222 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410005 CHANGSHA, HUNAN PROVINCE TO: 410004 CHANGSHA, HUNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141222 Address after: 410004, room 2, block D, 188 international business center, No. 402 environmental protection Avenue, Yuhua District, Hunan, Changsha Patentee after: Pudao Medicine Technology Co., Ltd., Hunan Prov. Address before: 410005, Hunan, Changsha province Furong South Road section 368 BOBO world city CTA wealth center, 24 floor Patentee before: Duan Lixin |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170831 Address after: 410008 Hunan province Changsha Wangcheng City Economic Development Zone Tongguanshan circular economy industrial base Patentee after: Hunan Yang Yang Pharmaceutical Co., Ltd. Address before: 410004, room 2, block D, 188 international business center, No. 402 environmental protection Avenue, Yuhua District, Hunan, Changsha Patentee before: Pudao Medicine Technology Co., Ltd., Hunan Prov. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 410008 Tongguan Circular Economy Industrial Base, Wangcheng Economic Development Zone, Changsha City, Hunan Province Patentee after: Hunan Jiudian Hongyang Pharmaceutical Co., Ltd. Address before: 410008 Tongguan Circular Economy Industrial Base, Wangcheng Economic Development Zone, Changsha City, Hunan Province Patentee before: Hunan Yang Yang Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |